Note Purchase AgreementNote Purchase Agreement • November 6th, 2020 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 6th, 2020 Company Industry JurisdictionThis Note Purchase Agreement (this “Agreement”), dated as of November 4, 2020, is entered into by and between Outlook Therapeutics, Inc., a Delaware corporation (“Company”), and Streeterville Capital, LLC, a Utah limited liability company, its successors and/or assigns (“Investor”).